Richtlijn Guillain-Barré syndroom

Monitoring in de progressieve faseLiteratuurAlshekhlee A, Hussain Z, Sultan B, Katirji B. Immunotherapy for Guillain-Barré syndrome in theUS hospitals. J Clin Neuromuscul Dis 2008;10(1):4-10.Asahina M, Kuwabara S, Suzuki A, Hattori T. Autonomic function in demyelinating and axonalsubtypes of Guillain-Barré syndrome. Acta Neurol Scand 2002;105(1):44-50.Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barrésyndrome. Muscle Nerve 2001;24(7):963-5.Cheng B-CC. Predictive factors and long-term outcome of respiratory failure after Guillain-Barrésyndrome. Am J Med Sci 2004;327(6):336-340.Chio AC. Guillain-Barré syndrome: A prospective, population-based incidence and outcomesurvey. Neurology 2003;60(7):1146-1150.Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, et al. Clinical andelectrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospectivestudy. Lancet Neurol 2006;5(12):1021-8.Flachenecker P, Müllges W, Wermuth P, Hartung HP, Reiners K. Eyeball pressure testing in theevaluation of serious bradyarrhythmias in Guillain-Barré syndrome. Neurology 1996;47(1):102-8.Flachenecker P, Wermuth P, Hartung HP, Reiners K. Quantitative assessment ofcardiovascular autonomic function in Guillain-Barré syndrome. Ann Neurol 1997;42(2):171-9.Flachenecker P, Lem K, Müllges W, Reiners K. Detection of serious bradyarrhythmias inGuillain-Barré syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum.Clin Auton Res 2000;10(4):185-91.Flachenecker P. Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis. JNeurol 2007;254 Suppl 2:II96-II101.French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Efficiency ofplasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol1987;22(6):753-61.Guillain-Barré Syndrome Steroid Trial Group.Double-blind trial of intravenousmethylprednisolone in Guillain-Barré syndrome. Lancet 1993;341(8845):586-90.Henderson RD, Lawn ND, Fletcher DD, McClelland RL, Wijdicks EF. The morbidity of Guillain-Barré syndrome admitted to the intensive care unit. Neurology 2003;60(1):17-21.Hughes RA, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Sladky JT, BarohnRJ, Stevens JC; Multidisciplinary Consensus Group. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol 2005;62(8):1194-8.Kleyweg RP, van der Meché FG, Schmitz PI. Axonal damage in Guillain-Barré syndrome.Muscle Nerve 1991;14(11):1103-9.113